Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017
Abstract This is a report on the CNS barrier congress held in London, UK, March 22–23rd 2017 and sponsored by Kisaco Research Ltd. The two 1-day sessions were chaired by John Greenwood and Margareta Hammarlund-Udenaes, respectively, and each session ended with a discussion led by the chair. Speakers...
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-11-01
|
Series: | Fluids and Barriers of the CNS |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12987-017-0079-9 |
id |
doaj-9f2b405af0e144599c2986f71ecc7708 |
---|---|
record_format |
Article |
spelling |
doaj-9f2b405af0e144599c2986f71ecc77082020-11-25T00:38:56ZengBMCFluids and Barriers of the CNS2045-81182017-11-0114111110.1186/s12987-017-0079-9Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017John Greenwood0Margareta Hammarlund-Udenaes1Hazel C. Jones2Alan W. Stitt3Roosmarijn E. Vandenbroucke4Ignacio A. Romero5Matthew Campbell6Gert Fricker7Birger Brodin8Heiko Manninga9Pieter J. Gaillard10Markus Schwaninger11Carl Webster12Krzysztof B. Wicher13Michel Khrestchatisky14Institute of Ophthalmology, University College LondonDepartment of Pharmaceutical Biosciences, Uppsala UniversityGagle Brook House, ChestertonCentre for Experimental Medicine, Queen’s University BelfastDepartment of Biomedical Molecular Biology, Ghent UniversitySchool of Life, Health and Chemical Sciences, Open UniversitySmurfit Institute of Genetics, Lincoln Place Gate, Trinity College DublinInstitute of Pharmacy and Molecular Biotechnology, Ruprecht-Karls UniversityDepartment of Pharmacy, Faculty of Health and Medical Sciences, University of CopenhagenNEUWAY Pharma GmbH2-BBB Medicines BVInstitute of Experimental and Clinical Pharmacology and Toxicology, University of LübeckAntibody Discovery and Protein Engineering, MedImmuneOssianix Inc.CNRS, NICN, Aix Marseille UnivAbstract This is a report on the CNS barrier congress held in London, UK, March 22–23rd 2017 and sponsored by Kisaco Research Ltd. The two 1-day sessions were chaired by John Greenwood and Margareta Hammarlund-Udenaes, respectively, and each session ended with a discussion led by the chair. Speakers consisted of invited academic researchers studying the brain barriers in relation to neurological diseases and industry researchers studying new methods to deliver therapeutics to treat neurological diseases. We include here brief reports from the speakers.http://link.springer.com/article/10.1186/s12987-017-0079-9Blood–brain barrierBlood–CSF barrierBlood–retinal barrierNeuroinflammationViral vectorsDrug delivery |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
John Greenwood Margareta Hammarlund-Udenaes Hazel C. Jones Alan W. Stitt Roosmarijn E. Vandenbroucke Ignacio A. Romero Matthew Campbell Gert Fricker Birger Brodin Heiko Manninga Pieter J. Gaillard Markus Schwaninger Carl Webster Krzysztof B. Wicher Michel Khrestchatisky |
spellingShingle |
John Greenwood Margareta Hammarlund-Udenaes Hazel C. Jones Alan W. Stitt Roosmarijn E. Vandenbroucke Ignacio A. Romero Matthew Campbell Gert Fricker Birger Brodin Heiko Manninga Pieter J. Gaillard Markus Schwaninger Carl Webster Krzysztof B. Wicher Michel Khrestchatisky Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017 Fluids and Barriers of the CNS Blood–brain barrier Blood–CSF barrier Blood–retinal barrier Neuroinflammation Viral vectors Drug delivery |
author_facet |
John Greenwood Margareta Hammarlund-Udenaes Hazel C. Jones Alan W. Stitt Roosmarijn E. Vandenbroucke Ignacio A. Romero Matthew Campbell Gert Fricker Birger Brodin Heiko Manninga Pieter J. Gaillard Markus Schwaninger Carl Webster Krzysztof B. Wicher Michel Khrestchatisky |
author_sort |
John Greenwood |
title |
Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017 |
title_short |
Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017 |
title_full |
Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017 |
title_fullStr |
Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017 |
title_full_unstemmed |
Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017 |
title_sort |
current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on cns barrier congress london, uk, 2017 |
publisher |
BMC |
series |
Fluids and Barriers of the CNS |
issn |
2045-8118 |
publishDate |
2017-11-01 |
description |
Abstract This is a report on the CNS barrier congress held in London, UK, March 22–23rd 2017 and sponsored by Kisaco Research Ltd. The two 1-day sessions were chaired by John Greenwood and Margareta Hammarlund-Udenaes, respectively, and each session ended with a discussion led by the chair. Speakers consisted of invited academic researchers studying the brain barriers in relation to neurological diseases and industry researchers studying new methods to deliver therapeutics to treat neurological diseases. We include here brief reports from the speakers. |
topic |
Blood–brain barrier Blood–CSF barrier Blood–retinal barrier Neuroinflammation Viral vectors Drug delivery |
url |
http://link.springer.com/article/10.1186/s12987-017-0079-9 |
work_keys_str_mv |
AT johngreenwood currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017 AT margaretahammarlundudenaes currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017 AT hazelcjones currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017 AT alanwstitt currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017 AT roosmarijnevandenbroucke currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017 AT ignacioaromero currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017 AT matthewcampbell currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017 AT gertfricker currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017 AT birgerbrodin currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017 AT heikomanninga currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017 AT pieterjgaillard currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017 AT markusschwaninger currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017 AT carlwebster currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017 AT krzysztofbwicher currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017 AT michelkhrestchatisky currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017 |
_version_ |
1725295768595595264 |